(CTSH) Cognizant Technology - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1924461023
Stock:
Total Rating 42
Risk 85
Buy Signal -0.72
| Risk 5d forecast | |
|---|---|
| Volatility | 43.0% |
| Relative Tail Risk | -4.97% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.99 |
| Alpha | -42.19 |
| Character TTM | |
|---|---|
| Beta | 0.894 |
| Beta Downside | 0.721 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.24% |
| CAGR/Max DD | 0.04 |
EPS (Earnings per Share)
Revenue
Description: CTSH Cognizant Technology
Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. It operates through four segments: Financial Services; Health Sciences; Products and Resources; and Communications, Media and Technology. The company provides services including artificial intelligence (AI) and other technology services and solutions, consulting, application development, systems integration, quality engineering and assurance, engineering research and development, application maintenance, infrastructure, security, and business process services and automation. It also offers AI-led automation, which includes advisory, and process and IT automation solutions designed to simplify and accelerate automation adoption; business process outsourcing services, which help deliver business outcomes including revenue growth, increased customer and employee satisfaction, and cost savings; and Cognizant Moment, a digital experience service that uses AI to reimagine customer experiences and engineer strategies aimed at driving growth. In addition, the company develops, licenses, implements, and supports proprietary and third-party software products and platforms; and develops industry-specific products and services. It offers solution to healthcare providers and payers, life sciences companies, banking, capital markets, payments and insurance companies, manufacturers, automakers, retailers, consumer goods, travel and hospitality, communications, media and entertainment, education, information services, and technology companies, as well as businesses providing logistics, energy, and utility services. The company has a strategic partnership with Uniphore Technologies Inc. for the development of AI solutions that combine small language models and AI agents. Cognizant Technology Solutions Corporation was incorporated in 1988 and is headquartered in Teaneck, New Jersey.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 2.23b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 3.39 > 1.0 |
| NWC/Revenue: 23.18% < 20% (prev 19.86%; Δ 3.32% < -1%) |
| CFO/TA 0.14 > 3% & CFO 2.88b > Net Income 2.23b |
| Net Debt (-326.0m) to EBITDA (4.07b): -0.08 < 3 |
| Current Ratio: 2.34 > 1.5 & < 3 |
| Outstanding Shares: last quarter (482.0m) vs 12m ago -3.02% < -2% |
| Gross Margin: 33.05% > 18% (prev 0.34%; Δ 3271 % > 0.5%) |
| Asset Turnover: 103.8% > 50% (prev 98.85%; Δ 4.98% > 0%) |
| Interest Coverage Ratio: 95.03 > 6 (EBITDA TTM 4.07b / Interest Expense TTM 37.0m) |
Altman Z'' 7.88
| A: 0.24 (Total Current Assets 8.55b - Total Current Liabilities 3.66b) / Total Assets 20.69b |
| B: 0.73 (Retained Earnings 15.16b / Total Assets 20.69b) |
| C: 0.17 (EBIT TTM 3.52b / Avg Total Assets 20.33b) |
| D: 2.64 (Book Value of Equity 15.00b / Total Liabilities 5.68b) |
| Altman-Z'' Score: 7.88 = AAA |
Beneish M -2.99
| DSRI: 1.02 (Receivables 4.44b/4.06b, Revenue 21.11b/19.74b) |
| GMI: 1.04 (GM 33.05% / 34.34%) |
| AQI: 0.94 (AQ_t 0.51 / AQ_t-1 0.55) |
| SGI: 1.07 (Revenue 21.11b / 19.74b) |
| TATA: -0.03 (NI 2.23b - CFO 2.88b) / TA 20.69b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of CTSH shares?
As of February 26, 2026, the stock is trading at USD 61.33 with a total of 11,162,190 shares traded.
Over the past week, the price has changed by -8.20%, over one month by -28.00%, over three months by -19.37% and over the past year by -26.42%.
Over the past week, the price has changed by -8.20%, over one month by -28.00%, over three months by -19.37% and over the past year by -26.42%.
Is CTSH a buy, sell or hold?
Cognizant Technology has received a consensus analysts rating of 3.33.
Therefor, it is recommend to hold CTSH.
- StrongBuy: 4
- Buy: 3
- Hold: 19
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the CTSH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 90.2 | 47.1% |
| Analysts Target Price | 90.2 | 47.1% |
CTSH Fundamental Data Overview February 21, 2026
P/E Trailing = 14.6374
P/E Forward = 12.1212
P/S = 1.486
P/B = 2.07
P/EG = 1.2003
Revenue TTM = 21.11b USD
EBIT TTM = 3.52b USD
EBITDA TTM = 4.07b USD
Long Term Debt = 543.0m USD (from longTermDebt, last quarter)
Short Term Debt = 186.0m USD (from shortTermDebt, last quarter)
Debt = 1.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -326.0m USD (from netDebt column, last quarter)
Enterprise Value = 31.03b USD (31.37b + Debt 1.57b - CCE 1.91b)
Interest Coverage Ratio = 95.03 (Ebit TTM 3.52b / Interest Expense TTM 37.0m)
EV/FCF = 11.96x (Enterprise Value 31.03b / FCF TTM 2.60b)
FCF Yield = 8.36% (FCF TTM 2.60b / Enterprise Value 31.03b)
FCF Margin = 12.29% (FCF TTM 2.60b / Revenue TTM 21.11b)
Net Margin = 10.56% (Net Income TTM 2.23b / Revenue TTM 21.11b)
Gross Margin = 33.05% ((Revenue TTM 21.11b - Cost of Revenue TTM 14.13b) / Revenue TTM)
Gross Margin QoQ = 31.11% (prev 33.87%)
Tobins Q-Ratio = 1.50 (Enterprise Value 31.03b / Total Assets 20.69b)
Interest Expense / Debt = 0.51% (Interest Expense 8.00m / Debt 1.57b)
Taxrate = 26.61% (235.0m / 883.0m)
NOPAT = 2.58b (EBIT 3.52b * (1 - 26.61%))
Current Ratio = 2.34 (Total Current Assets 8.55b / Total Current Liabilities 3.66b)
Debt / Equity = 0.10 (Debt 1.57b / totalStockholderEquity, last quarter 15.02b)
Debt / EBITDA = -0.08 (Net Debt -326.0m / EBITDA 4.07b)
Debt / FCF = -0.13 (Net Debt -326.0m / FCF TTM 2.60b)
Total Stockholder Equity = 15.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.97% (Net Income 2.23b / Total Assets 20.69b)
RoE = 14.84% (Net Income TTM 2.23b / Total Stockholder Equity 15.02b)
RoCE = 22.59% (EBIT 3.52b / Capital Employed (Equity 15.02b + L.T.Debt 543.0m))
RoIC = 16.53% (NOPAT 2.58b / Invested Capital 15.61b)
WACC = 8.79% (E(31.37b)/V(32.94b) * Re(9.21%) + D(1.57b)/V(32.94b) * Rd(0.51%) * (1-Tc(0.27)))
Discount Rate = 9.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.91%
[DCF] Terminal Value 74.15% ; FCFF base≈2.29b ; Y1≈2.14b ; Y5≈1.99b
[DCF] Fair Price = 64.96 (EV 30.74b - Net Debt -326.0m = Equity 31.07b / Shares 478.2m; r=8.79% [WACC]; 5y FCF grow -8.14% → 2.90% )
EPS Correlation: 63.74 | EPS CAGR: 6.13% | SUE: 0.72 | # QB: 0
Revenue Correlation: 79.62 | Revenue CAGR: 2.70% | SUE: 0.67 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.34 | Chg7d=-0.003 | Chg30d=-0.004 | Revisions Net=-8 | Analysts=20
EPS current Year (2026-12-31): EPS=5.66 | Chg7d=-0.007 | Chg30d=+0.027 | Revisions Net=+8 | Growth EPS=+7.1% | Growth Revenue=+5.9%
EPS next Year (2027-12-31): EPS=6.15 | Chg7d=-0.005 | Chg30d=+0.026 | Revisions Net=+6 | Growth EPS=+8.8% | Growth Revenue=+5.4%
[Analyst] Revisions Ratio: -0.50 (4 Up / 12 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.4% (Discount Rate 9.2% - Earnings Yield 6.8%)
[Growth] Growth Spread = +3.4% (Analyst 5.8% - Implied 2.4%)
P/E Forward = 12.1212
P/S = 1.486
P/B = 2.07
P/EG = 1.2003
Revenue TTM = 21.11b USD
EBIT TTM = 3.52b USD
EBITDA TTM = 4.07b USD
Long Term Debt = 543.0m USD (from longTermDebt, last quarter)
Short Term Debt = 186.0m USD (from shortTermDebt, last quarter)
Debt = 1.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -326.0m USD (from netDebt column, last quarter)
Enterprise Value = 31.03b USD (31.37b + Debt 1.57b - CCE 1.91b)
Interest Coverage Ratio = 95.03 (Ebit TTM 3.52b / Interest Expense TTM 37.0m)
EV/FCF = 11.96x (Enterprise Value 31.03b / FCF TTM 2.60b)
FCF Yield = 8.36% (FCF TTM 2.60b / Enterprise Value 31.03b)
FCF Margin = 12.29% (FCF TTM 2.60b / Revenue TTM 21.11b)
Net Margin = 10.56% (Net Income TTM 2.23b / Revenue TTM 21.11b)
Gross Margin = 33.05% ((Revenue TTM 21.11b - Cost of Revenue TTM 14.13b) / Revenue TTM)
Gross Margin QoQ = 31.11% (prev 33.87%)
Tobins Q-Ratio = 1.50 (Enterprise Value 31.03b / Total Assets 20.69b)
Interest Expense / Debt = 0.51% (Interest Expense 8.00m / Debt 1.57b)
Taxrate = 26.61% (235.0m / 883.0m)
NOPAT = 2.58b (EBIT 3.52b * (1 - 26.61%))
Current Ratio = 2.34 (Total Current Assets 8.55b / Total Current Liabilities 3.66b)
Debt / Equity = 0.10 (Debt 1.57b / totalStockholderEquity, last quarter 15.02b)
Debt / EBITDA = -0.08 (Net Debt -326.0m / EBITDA 4.07b)
Debt / FCF = -0.13 (Net Debt -326.0m / FCF TTM 2.60b)
Total Stockholder Equity = 15.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.97% (Net Income 2.23b / Total Assets 20.69b)
RoE = 14.84% (Net Income TTM 2.23b / Total Stockholder Equity 15.02b)
RoCE = 22.59% (EBIT 3.52b / Capital Employed (Equity 15.02b + L.T.Debt 543.0m))
RoIC = 16.53% (NOPAT 2.58b / Invested Capital 15.61b)
WACC = 8.79% (E(31.37b)/V(32.94b) * Re(9.21%) + D(1.57b)/V(32.94b) * Rd(0.51%) * (1-Tc(0.27)))
Discount Rate = 9.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.91%
[DCF] Terminal Value 74.15% ; FCFF base≈2.29b ; Y1≈2.14b ; Y5≈1.99b
[DCF] Fair Price = 64.96 (EV 30.74b - Net Debt -326.0m = Equity 31.07b / Shares 478.2m; r=8.79% [WACC]; 5y FCF grow -8.14% → 2.90% )
EPS Correlation: 63.74 | EPS CAGR: 6.13% | SUE: 0.72 | # QB: 0
Revenue Correlation: 79.62 | Revenue CAGR: 2.70% | SUE: 0.67 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.34 | Chg7d=-0.003 | Chg30d=-0.004 | Revisions Net=-8 | Analysts=20
EPS current Year (2026-12-31): EPS=5.66 | Chg7d=-0.007 | Chg30d=+0.027 | Revisions Net=+8 | Growth EPS=+7.1% | Growth Revenue=+5.9%
EPS next Year (2027-12-31): EPS=6.15 | Chg7d=-0.005 | Chg30d=+0.026 | Revisions Net=+6 | Growth EPS=+8.8% | Growth Revenue=+5.4%
[Analyst] Revisions Ratio: -0.50 (4 Up / 12 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.4% (Discount Rate 9.2% - Earnings Yield 6.8%)
[Growth] Growth Spread = +3.4% (Analyst 5.8% - Implied 2.4%)